OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Bupathi on the Evolving Treatment Landscape of Bladder Cancer

December 3rd 2021

Manojkumar Bupathi, MD, MS, discusses the evolving treatment landscape of bladder cancer.

Dr. Raghav on Treatment Considerations With Regorafenib and TAS-102 in CRC

December 3rd 2021

Kanwal Raghav, MBBS, MD, discusses the safety profiles of regorafenib and trifluridine/tipiracil, and selecting between the agents for the treatment of patients with colorectal cancer.

Dr. Grivas on Enfortumab Vedotin in Second- and Third-Line Urothelial Carcinoma

December 3rd 2021

Petros Grivas, MD, PhD, discusses the utility of enfortumab vedotin-ejfv in the second- and third-line setting for patients with urothelial carcinoma.

Dr. Leal on the Evolution of Treatment in EGFR Exon 20 Insertion+ NSCLC

December 2nd 2021

Ticiana Leal, MD, discusses the evolution of treatment in EGFR exon 20 insertion–positive non–small cell lung cancer.

Dr. Pothuri on the Challenges of POLE Testing in Endometrial Cancer

December 2nd 2021

Bhavana Pothuri, MD, discusses the challenges of DNA polymerase epsilon mutation testing in endometrial cancer.

Dr. Lee on Treatment Considerations in Smoldering Multiple Myeloma

December 2nd 2021

Sarah S. Lee, MD, discusses treatment considerations in smoldering multiple myeloma.

Dr. Rose on the Importance of Genetic Testing in Ovarian Cancer

December 2nd 2021

Stephen L. Rose, MD, UW Health, discusses the importance of genetic testing in ovarian cancer.

Dr. Allison on the Urgency of Drug Development in Oncology

December 2nd 2021

James P. Allison, PhD, discusses his experience with the urgency of drug development in oncology.

Dr. Thaker on the Importance of Surveying Patients on Unmet Needs in Ovarian Cancer

December 2nd 2021

Premal Thaker, MD, MS, discusses the importance of surveying patients on unmet needs in ovarian cancer.

Dr. Luke on Toxicities With Targeted Therapy Vs Immunotherapy in Melanoma

December 1st 2021

Jason J. Luke, MD, FACP, discusses the toxicities with targeted therapy vs immunotherapy and management strategies for patients with melanoma.

Dr. Chauncey on Isatuximab Combinations in Multiple Myeloma

December 1st 2021

Thomas R. Chauncey, MD, PhD, discusses the phase 3 ICARIA-MM trial and IKEMA trials with isatuximab-irfc combinations in patients with relapsed or refractory multiple myeloma.

Dr. Garon on the Potential Clinical Implications of the TROPION-Lung01 Trial in NSCLC

December 1st 2021

Edward B. Garon, MD, discusses the potential impact of the ongoing, phase 3 TROPION-LUNG01 trial in non–small cell lung cancer.

Dr. Harrison on the Current State of Treatment in Myelofibrosis

December 1st 2021

Claire Harrison, MD, FRCP, FRCPath, discusses the current state of treatment in myelofibrosis.

Dr. Chen on Risk Factors for Developing cGVHD

December 1st 2021

Yi-Bin Chen, MD, discusses risk factors for developing chronic graft-vs-host disease in patients who receive an allogeneic transplant.

Dr. Neumann on Tapering Steroids in cGVHD

December 1st 2021

Joyce L. Neumann, PhD, APRN, AOCN, BMTCN, FAAN, discusses tapering steroids for patients with chronic graft-vs-host disease.

Fellows on Film: How To Market Yourself for a Fellowship

November 30th 2021

Richard J. Bleicher, MD, FACS, and Salvatore Nardello, DO, discuss how to market oneself for a fellowship in oncology.

Fellows on Film: How to Be a Good Mentor for Fellows

November 30th 2021

Richard J. Bleicher, MD, FACS, and Salvatore Nardello, DO, discuss how to be a good mentor for fellows in oncology.

Fellows on Film: The Importance of Having a Mentor

November 30th 2021

Richard J. Bleicher, MD, FACS, and Salvatore Nardello, DO, discuss the importance of having a mentor during fellowship.

Dr. Allison on the Impact of Immunotherapy in Cancer

November 30th 2021

James P. Allison, PhD, discusses the impact of immunotherapy on patients with cancer.

Dr. Allison on the Development of Ipilimumab for Cancer Treatment

November 30th 2021

James P. Allison, PhD, discusses the development of ipilimumab.